Inherited disorders of iron metabolism

Current Opinion in Pediatrics

Volumn 23, Issue 1, 2011, Pages 14-20

  Camaschella, Clara ^a   Poggiali, Erika ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; FLUROTHYL; HEMOJUVELIN; HEPCIDIN;

ARTICLE; DIFFERENTIAL DIAGNOSIS; HEMOCHROMATOSIS; HYPERFERRITINEMIA; IRON DEFICIENCY ANEMIA; IRON METABOLISM DISORDER; IRON TRANSPORT; METABOLIC REGULATION; MICROCYTIC ANEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIDEROBLASTIC ANEMIA;

ANTIMICROBIAL CATIONIC PEPTIDES; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRON METABOLISM DISORDERS; MEMBRANE PROTEINS; SERINE ENDOPEPTIDASES;

EID: 78751628651     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283425591     Document Type: Article

References (51)

1. Hentze MW, Hentze MW, Muckenthaler MU, et al. Two to tango: regulation of mammalian iron metabolism. Cell 2010; 142:24-38.
2. Mastrogiannaki M, Matak P, Keith B, et al. HIF-2a, but not HIF-1a, promotes iron absorption in mice. J Clin Invest 2009; 119:1159-1166.
3. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-2093.
4. Keel SB, Doty RT, Yang Z, et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008; 319:825-828.
5. Oudit GY, Sun H, Trivieri MG, et al. L-type Ca2-channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003; 9:1187-1194.
6. Zhang DL, Hughes RM, Ollivierre-Wilson H, et al. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 2009; 9:461-473.
7. Camaschella C. BMP6 orchestrates iron metabolism. Nat Genet 2009; 41:386-388.
8. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis and treatment. Gastroenterology 2010; 139:393-408.
9. Adams PC, Reboussin DM, Barton JC, et al., Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005; 352:1769-1779.
10. Camaschella C, Poggiali E. Rare types of genetic hemochromatosis. Acta Haematol 2009; 122:140-145
11. MacFarlane J, Papanikalaou G, Goldberg YP. Juvenile hereditary hemochromatosis. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. Gene- Reviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993
12. Camaschella C, Roetto A. TFR2-related hereditary hemochromatosis. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2005 [updated 5 Aug 2008].
13. De Domenico I, Ward DM, Langelier C, et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 2007; 18:2569-2578.
14. McLaren CE, Barton JC, Gordeuk VR, et al. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study. Am J Hematol 2007; 82:898-905.
15. Allen KJ, Bertalli NA, Osborne NJ, et al. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology 2010; 52:925-933.
16. Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008; 358:221-230
17. European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010; 53:3-22.
18. Adams PC, Barton JC. How I treat hemochromatosis? Blood 2010; 116:317-325
19. Phatak P, Brissot P, Wurster M, et al. A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology 2010; 52:11338-11352.
20. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008; 40:569-571.
21. Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008; 320:1088-1092
22. Folgueras AR, de Lara FM, Pendas AM, et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 2008; 112:2539-2545.
23. Silvestri L, Guillem F, Pagani A, et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood 2009; 113:5605-5608.
24. De Falco L, Totaro F, Nai A, et al. Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA). Hum Mutat 2010; 31:E1390-E1405.
25. Silvestri L, Pagani A, Nai A, et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008; 8:502-511.
26. Finberg KE, Whittlesey RL, Fleming MD, Andrews NC. Down-regulation of BMP/SMAD signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 2010; 115:3817-3826
27. Benyamin B, Ferreira MA, Willemsen G, et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 2009; 41:1173-1175
28. Tanaka T, Roy CN, Yao W, et al. A genome-wide association analysis of serum iron concentrations. Blood 2010; 7:94-96.
29. Ganesh SK, Zakai NA, van Rooij FJ, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009; 41:1191-1198.
30. Nai A, Pagani A, Silvestri L, Camaschella C. Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient mice. Blood 2010; 116:851-852.
31. Finberg KE. Iron-refractory iron deficiency anemia. Semin Hematol 2009; 46:378-386
32. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011-1023.
33. Melis MA, Cau M, Congiu R, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008; 93:1473-1479.
34. Ramsay AJ, Quesada V, Sanchez M, et al. Matriptase-2 mutations in ironrefractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum Mol Genet 2009; 18:3673-3683.
35. Guillem F, Lawson S, Kannengiesser C, et al. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 2008; 112:2089-2091.
36. Altamura S, D'Alessio F, Selle B, Muckenthaler M. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA. Biochem J 2010; 431:363-371.
37. Tchou I, Diepold M, Pilotto PA, et al. Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia. Eur J Haematol 2009; 83:595-602.
38. Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood 2008; 112:4292-4297.
39. Trombini P, Coliva T, Nemeth E, et al. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica 2007; 92:1407-1410.
40. Iolascon A, Camaschella C, Pospisilova D, et al. Natural history of recessive inheritance of DMT1 mutations. J Pediatr 2008; 152:136-139.
41. Guernsey DL, Jiang H, Campagna DR, et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 2009; 41:651-653.
42. Ye H, Jeong SY, Ghosh MC, et al. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J Clin Invest 2010; 120:1749-1761.
43. Camaschella C, Campanella A, De Falco L, et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 2007; 110:1353-1358.
44. Wingert RA, Galloway JL, Barut B, et al. Tübingen 2000 Screen Consortium. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005; 436:1035-1039. (Pubitemid 41191688)
45. Iolascon A, De Falco L, Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica 2009; 94:395-408.
46. Miyajima H. Aceruloplasminemia. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2003 [updated 15 May 2008].
47. Boddaert N, Le Quan Sang KH, Rötig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007; 110:401-408.
48. Arnold J, Sangwaiya A, Manglam V, et al. Hepcidin levels in hereditary hyperferritinemia: insights into the iron-sensing mechanism in hepatocytes. World J Gastroenterol 2010; 16:3541-3545.
49. Cozzi A, Rovelli E, Frizzale G, et al. Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy. Neurobiol Dis 2010; 37:77-85.
50. Nemeth E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol doi:10.1155/2010/750643.
51. Li H, Ginzburg YZ. Crosstalk between iron metabolism and erythropoiesis. Adv Hematol doi:10.1155/2010/605435.